Harvard Heart Letter

Beyond statins: New medicines for hard-to-manage cholesterol

Statins are usually the first choice to lower LDL cholesterol levels in most people who need medications, but some still fail to reach their desired targets. A new class of drugs called PCSK9 inhibitors may be able to pick up the slack.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In